Equine Medical Center of Ocala

COMMITTED TO THE HEALTH OF HORSES

Our reputation stems from our unwavering commitment to quality, both in the care of horses and in our relationship with clients and community.

News

  • IRAP

    “IRAP” or Interleukin-1 Receptor Antagonist Protein (IRAP) is an exciting new articular therapy available at our hospital.


Upcoming Events

02/04/2007

IRAP


“IRAP” or Interleukin-1 Receptor Antagonist Protein (IRAP) is an exciting new articular therapy available at our hospital.

Category: News
Posted by: admin

“IRAP” or Interleukin-1 Receptor Antagonist Protein (IRAP) is an exciting new articular therapy available at our hospital. Interleukin-1(IL-1) was originally identified as a regulator of cartilage function in 1977. Today, IL-1 is recognized for its capacity to produce most, if not all, of the enzymes that are involved in cartilage destruction. Using 60 mls of equine blood, a manufacturing kit and the incubator in our hospital lab, we can produce an enzyme that blocks the actions of IL-1 called Interleukin-1 receptor antagonist protein (IRAP).

It is used principally for horses that are no longer getting a positive response from hyaluronic acid (Acid) or depomedrol (cortisone), or for horses that must compete in a drug free environment. Please contact Dr. Peloso at the clinic if you have additional questions regarding this new and exciting articular therapy

© 2008 Equine Medical Center of Ocala